Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

A Multiple Stakeholder Multicriteria Decision Analysis in Diabetic Macular Edema Management: The MULTIDEX-EMD Study.

de Andrés-Nogales F, Casado MÁ, Trillo JL, Ruiz-Moreno JM, Martínez-Sesmero JM, Peralta G, Poveda JL, Ortiz P, Ignacio E, Zarranz-Ventura J, Udaondo P, Mur C, Álvarez E, Cervera E, Martínez M, Llorente I, Zulueta J, Rodríguez-Maqueda M, García-Layana A, Martínez-Olmos J.

Pharmacoecon Open. 2020 Feb 25. doi: 10.1007/s41669-020-00201-2. [Epub ahead of print]

PMID:
32100249
2.

Evaluation of microvascular changes in the perifoveal vascular network using optical coherence tomography angiography (OCTA) in type I diabetes mellitus: a large scale prospective trial.

Zarranz-Ventura J, Barraso M, Alé-Chilet A, Hernandez T, Oliva C, Gascón J, Sala-Puigdollers A, Figueras-Roca M, Vinagre I, Ortega E, Esmatjes E, Adan A.

BMC Med Imaging. 2019 Nov 21;19(1):91. doi: 10.1186/s12880-019-0391-8.

3.

Predictive capacity of baseline hyperreflective dots on the intravitreal dexamethasone implant (Ozurdex®) outcomes in diabetic macular edema: a multicenter study.

Fonollosa A, Zarranz-Ventura J, Valverde A, Becerra E, Bernal-Morales C, Pastor-Idoate S, Zapata MA.

Graefes Arch Clin Exp Ophthalmol. 2019 Nov;257(11):2381-2390. doi: 10.1007/s00417-019-04446-4. Epub 2019 Aug 26.

PMID:
31451909
4.

Validation of automated artificial intelligence segmentation of optical coherence tomography images.

Maloca PM, Lee AY, de Carvalho ER, Okada M, Fasler K, Leung I, Hörmann B, Kaiser P, Suter S, Hasler PW, Zarranz-Ventura J, Egan C, Heeren TFC, Balaskas K, Tufail A, Scholl HPN.

PLoS One. 2019 Aug 16;14(8):e0220063. doi: 10.1371/journal.pone.0220063. eCollection 2019.

5.

Aqueous Humour Cytokine Changes with Intravitreal Dexamethasone Implant Injection for Diabetic Macular Edema.

Figueras-Roca M, Sala-Puigdollers A, Alforja S, Torras J, Peraza-Nieves J, Zarranz-Ventura J, Adan Civera A, Molins B.

Ocul Immunol Inflamm. 2019;27(8):1203-1210. doi: 10.1080/09273948.2019.1636095. Epub 2019 Aug 16.

PMID:
31418610
6.

Safety of 6000 intravitreal dexamethasone implants.

Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; for International Ozurdex Study Group.

Br J Ophthalmol. 2020 Jan;104(1):39-46. doi: 10.1136/bjophthalmol-2019-313991. Epub 2019 Apr 30.

PMID:
31040132
7.

Long-Term Intravitreal Dexamethasone Implant Outcomes in Uveitis.

Alba-Linero C, Sala-Puigdollers A, Romero B, Llorenç V, Adan A, Zarranz-Ventura J.

Ocul Immunol Inflamm. 2020;28(2):228-237. doi: 10.1080/09273948.2019.1578380. Epub 2019 Apr 17.

PMID:
30994370
8.

Anatomic Response to Intravitreal Dexamethasone Implant and Baseline Aqueous Humor Cytokine Levels in Diabetic Macular Edema.

Figueras-Roca M, Sala-Puigdollers A, Zarranz-Ventura J, Alba-Linero C, Alforja S, Esquinas C, Molins B, Adán A.

Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1336-1343. doi: 10.1167/iovs.18-26215.

PMID:
30933261
9.

Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world.

Zarranz-Ventura J, Sala-Puigdollers A, Velazquez-Villoria D, Figueras-Roca M, Copete S, Distefano L, Boixadera A, García-Arumi J, Adan A; Hospital Clínic—Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group.

PLoS One. 2019 Jan 4;14(1):e0209997. doi: 10.1371/journal.pone.0209997. eCollection 2019.

10.

Novel Association of High C-Reactive Protein Levels and A69S at Risk Alleles in Wet Age-Related Macular Degeneration Women.

Fernandez-Robredo P, Recalde S, Hernandez M, Zarranz-Ventura J, Molins B, Casaroli-Marano RP, Adan A, Saenz-de-Viteri M, García-Layana A.

Front Immunol. 2018 Aug 14;9:1862. doi: 10.3389/fimmu.2018.01862. eCollection 2018.

11.

Repeatability and reproducibility of retinal and choroidal thickness measurements in Diabetic Macular Edema using Swept-source Optical Coherence Tomography.

Sala-Puigdollers A, Figueras-Roca M, Hereu M, Hernández T, Morató M, Adán A, Zarranz-Ventura J.

PLoS One. 2018 Jul 26;13(7):e0200819. doi: 10.1371/journal.pone.0200819. eCollection 2018.

12.

PREVALENCE OF FOVEOLAR LUCENCY WITH DIFFERENT GAS TAMPONADES IN SURGICALLY CLOSED MACULAR HOLES ASSESSED BY SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.

Zarranz-Ventura J, Ellabban AA, Sim DA, Keane PA, Kirkpatrick JN, Sallam AAB.

Retina. 2018 Sep;38(9):1699-1706. doi: 10.1097/IAE.0000000000001762.

PMID:
28699926
13.

C-reactive protein isoforms differentially affect outer blood-retinal barrier integrity and function.

Molins B, Pascual A, Méndez, Llorenç V, Zarranz-Ventura J, Mesquida M, Adán A, Martorell J.

Am J Physiol Cell Physiol. 2017 Mar 1;312(3):C244-C253. doi: 10.1152/ajpcell.00057.2016. Epub 2016 Dec 21.

14.

The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care.

Liew G, Lee AY, Zarranz-Ventura J, Stratton I, Bunce C, Chakravarthy U, Lee CS, Keane PA, Sim DA, Akerele T, McKibbin M, Downey L, Natha S, Bailey C, Khan R, Antcliff R, Armstrong S, Varma A, Kumar V, Tsaloumas M, Mandal K, Egan C, Johnston RL, Tufail A.

Eye (Lond). 2016 Nov;30(11):1462-1468. doi: 10.1038/eye.2016.149. Epub 2016 Jul 15.

15.

UK Neovascular Age-Related Macular Degeneration Database. Report 6: time to retreatment after a pause in therapy. Outcomes from 92 976 intravitreal ranibizumab injections.

Madhusudhana KC, Lee AY, Keane PA, Chakravarthy U, Johnston RL, Egan CA, Sim D, Zarranz-Ventura J, Tufail A, McKibbin M; UK AMD EMR Study Group.

Br J Ophthalmol. 2016 Dec;100(12):1617-1622. doi: 10.1136/bjophthalmol-2015-308077. Epub 2016 Mar 30.

PMID:
27030276
16.

Interleukin-22 serum levels are elevated in active scleritis.

Sainz-de-la-Maza M, Molins B, Mesquida M, Llorenç V, Zarranz-Ventura J, Sala-Puigdollers A, Matas J, Adan A, Foster CS.

Acta Ophthalmol. 2016 Sep;94(6):e395-9. doi: 10.1111/aos.13005. Epub 2016 Mar 24.

17.

Optical Coherence Tomography Features Of Active And Inactive Retinal Neovascularization In Proliferative Diabetic Retinopathy.

Vaz-Pereira S, Zarranz-Ventura J, Sim DA, Keane PA, Smith R, Egan CA, Tufail A.

Retina. 2016 Jun;36(6):1132-42. doi: 10.1097/IAE.0000000000000869.

PMID:
26630315
18.

Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy.

Zarranz-Ventura J, Keane PA, Sim DA, Llorens V, Tufail A, Sadda SR, Dick AD, Lee RW, Pavesio C, Denniston AK, Adan A; EQUATOR Study Group.

Am J Ophthalmol. 2016 Jan;161:172-80.e1-4. doi: 10.1016/j.ajo.2015.10.009. Epub 2015 Oct 23.

19.

Structural changes of the choroid in sarcoid- and tuberculosis-related granulomatous uveitis.

Mehta H, Sim DA, Keane PA, Zarranz-Ventura J, Gallagher K, Egan CA, Westcott M, Lee RW, Tufail A, Pavesio CE.

Eye (Lond). 2015 Aug;29(8):1060-8. doi: 10.1038/eye.2015.65. Epub 2015 May 29.

20.

Quantitative analysis of peripheral vasculitis, ischemia, and vascular leakage in uveitis using ultra-widefield fluorescein angiography.

Karampelas M, Sim DA, Chu C, Carreno E, Keane PA, Zarranz-Ventura J, Westcott M, Lee RW, Pavesio CE.

Am J Ophthalmol. 2015 Jun;159(6):1161-1168.e1. doi: 10.1016/j.ajo.2015.02.009. Epub 2015 Feb 21.

PMID:
25709064
21.

Retinal vessel caliber changes in vasculitis.

Liew G, Tufail A, Cosatto VF, Tan AG, Zarranz-Ventura J, Sim DA, Kean PA, Egan CA, Mitchell P, Westcott MC, Lee RW, Pavesio CE.

Retina. 2015 Apr;35(4):803-8. doi: 10.1097/IAE.0000000000000369.

PMID:
25526098
22.

Bow-string technique for iris pupilloplasty and posterior iris-claw artisan intraocular lens implant in traumatic aphakia with associated iris defects.

Zarranz-Ventura J, OʼConnell E, Haynes RJ.

Retina. 2014 Nov;34(11):2306-10. doi: 10.1097/IAE.0000000000000357. No abstract available.

PMID:
25285811
23.

Reevaluating the definition of intraretinal microvascular abnormalities and neovascularization elsewhere in diabetic retinopathy using optical coherence tomography and fluorescein angiography.

Lee CS, Lee AY, Sim DA, Keane PA, Mehta H, Zarranz-Ventura J, Fruttiger M, Egan CA, Tufail A.

Am J Ophthalmol. 2015 Jan;159(1):101-10.e1. doi: 10.1016/j.ajo.2014.09.041. Epub 2014 Oct 25.

24.

Multicenter study of intravitreal dexamethasone implant in noninfectious uveitis: indications, outcomes, and reinjection frequency.

Zarranz-Ventura J, Carreño E, Johnston RL, Mohammed Q, Ross AH, Barker C, Fonollosa A, Artaraz J, Pelegrin L, Adan A, Lee RW, Dick AD, Sallam A.

Am J Ophthalmol. 2014 Dec;158(6):1136-1145.e5. doi: 10.1016/j.ajo.2014.09.003. Epub 2014 Sep 8.

PMID:
25217856
25.

The neovascular age-related macular degeneration database: report 2: incidence, management, and visual outcomes of second treated eyes.

Zarranz-Ventura J, Liew G, Johnston RL, Xing W, Akerele T, McKibbin M, Downey L, Natha S, Chakravarthy U, Bailey C, Khan R, Antcliff R, Armstrong S, Varma A, Kumar V, Tsaloumas M, Mandal K, Bunce C, Tufail A; United Kingdom Age-Related Macular Degeneration Electronic Medical Records Users Group.

Ophthalmology. 2014 Oct;121(10):1966-75. doi: 10.1016/j.ophtha.2014.04.026. Epub 2014 Jun 20.

PMID:
24953791
26.

Bilateral and Simultaneous Intraocular Lens Subluxation in Essential Blepharospasm.

Moreno-Montañés J, Sabater AL, Guarnieri A, Zarranz-Ventura J, Riverol M.

Mov Disord Clin Pract. 2014 Jun 13;1(3):247-248. doi: 10.1002/mdc3.12049. eCollection 2014 Sep. No abstract available.

27.

Characterization of punctate inner choroidopathy using enhanced depth imaging optical coherence tomography.

Zarranz-Ventura J, Sim DA, Keane PA, Patel PJ, Westcott MC, Lee RW, Tufail A, Pavesio CE.

Ophthalmology. 2014 Sep;121(9):1790-7. doi: 10.1016/j.ophtha.2014.03.011. Epub 2014 May 20.

PMID:
24856311
28.

Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Saenz-de-Viteri M, Fernández-Robredo P, de Nova E, Bonet-Farriol E, Sabater AL, Zarranz-Ventura J, Caire J, Sádaba LM, Salinas-Alamán A, García-Layana A.

Int J Ophthalmol. 2013 Dec 18;6(6):801-4. doi: 10.3980/j.issn.2222-3959.2013.06.11. eCollection 2013.

29.

Predictive factors for the progression of diabetic macular ischemia.

Sim DA, Keane PA, Zarranz-Ventura J, Bunce CV, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Am J Ophthalmol. 2013 Oct;156(4):684-92. doi: 10.1016/j.ajo.2013.05.033. Epub 2013 Jul 24.

PMID:
23891332
30.

Transforming growth factor-beta inhibition reduces progression of early choroidal neovascularization lesions in rats: P17 and P144 peptides.

Zarranz-Ventura J, Fernández-Robredo P, Recalde S, Salinas-Alamán A, Borrás-Cuesta F, Dotor J, García-Layana A.

PLoS One. 2013 May 31;8(5):e65434. doi: 10.1371/journal.pone.0065434. Print 2013.

31.

Massive lipid exudation and retinal detachment after combined brachytherapy and transpupillary thermotherapy in choroidal melanoma.

Zarranz-Ventura J, Salinas-Alamán A, Barrio-Barrio J, de Nova E, Bonet E, García-Layana A.

Arch Soc Esp Oftalmol. 2013 May;88(5):197-200. doi: 10.1016/j.oftal.2012.02.012. Epub 2012 Jun 4. English, Spanish.

PMID:
23623022
32.

Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography.

Sim DA, Keane PA, Mehta H, Fung S, Zarranz-Ventura J, Fruttiger M, Patel PJ, Egan CA, Tufail A.

Invest Ophthalmol Vis Sci. 2013 Apr 23;54(4):2893-901. doi: 10.1167/iovs.12-11085.

PMID:
23538058
33.

Choroidal assessment in idiopathic panuveitis using optical coherence tomography.

Karampelas M, Sim DA, Keane PA, Zarranz-Ventura J, Patel PJ, Tufail A, Westcott M, Lee R, Pavesio CE.

Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):2029-36. doi: 10.1007/s00417-013-2330-7. Epub 2013 Mar 28.

PMID:
23532454
34.

The effects of macular ischemia on visual acuity in diabetic retinopathy.

Sim DA, Keane PA, Zarranz-Ventura J, Fung S, Powner MB, Platteau E, Bunce CV, Fruttiger M, Patel PJ, Tufail A, Egan CA.

Invest Ophthalmol Vis Sci. 2013 Mar 28;54(3):2353-60. doi: 10.1167/iovs.12-11103.

PMID:
23449720
35.

Azithromycin reduces inflammation in a rat model of acute conjunctivitis.

Fernandez-Robredo P, Recalde S, Moreno-Orduña M, García-García L, Zarranz-Ventura J, García-Layana A.

Mol Vis. 2013;19:153-65. Epub 2013 Jan 28.

36.

Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.

Recalde S, Zarranz-Ventura J, Fernández-Robredo P, García-Gómez PJ, Salinas-Alamán A, Borrás-Cuesta F, Dotor J, García-Layana A.

Invest Ophthalmol Vis Sci. 2011 Sep 9;52(10):7090-7. doi: 10.1167/iovs.11-7300.

PMID:
21810978
37.

[Genetics and ARMD: from the laboratory to the consulting room].

García Layana A, Zarranz-Ventura J, Fernández Robredo P, Recalde S, Rodríguez de Córdoba S; Grupo Español de Investigación Cooperativa en DMAE.

Arch Soc Esp Oftalmol. 2011 Apr;86(4):101-2. doi: 10.1016/j.oftal.2011.03.005. Spanish. No abstract available.

PMID:
21569917
38.

Intravitreal bevacizumab associated with grid laser photocoagulation in macular edema secondary to branch retinal vein occlusion.

Salinas-Alamán A, Zarranz-Ventura J, Caire González-Jauregui JM, Sádaba-Echarri LM, Barrio-Barrio J, García-Layana A.

Eur J Ophthalmol. 2011 Jul-Aug;21(4):434-9. doi: 10.5301/EJO.2010.6101.

PMID:
21140369
39.

[Acrysof(®) toric intraocular lens implantation in cataract surgery].

Zarranz-Ventura J, Moreno-Montañés J, Caire Y González-Jáuregui J, de Nova Fernández-Yáñez E, Sádaba-Echarri LM.

Arch Soc Esp Oftalmol. 2010 Aug;85(8):274-7. doi: 10.1016/j.oftal.2010.09.002. Epub 2010 Oct 30. Spanish.

PMID:
21130943
40.

[Dietary fat intake and incidence of cataracts: The SUN Prospective study in the cohort of Navarra, Spain].

Martínez-Lapiscina EH, Martínez-González MA, Guillén Grima F, Olmo Jiménez N, Zarranz-Ventura J, Moreno-Montañés J.

Med Clin (Barc). 2010 Feb 20;134(5):194-201. doi: 10.1016/j.medcli.2009.09.041. Epub 2010 Jan 6. Spanish.

PMID:
20056254
41.

Cirrus high-definition optical coherence tomography compared with Stratus optical coherence tomography in glaucoma diagnosis.

Moreno-Montañés J, Olmo N, Alvarez A, García N, Zarranz-Ventura J.

Invest Ophthalmol Vis Sci. 2010 Jan;51(1):335-43. doi: 10.1167/iovs.08-2988. Epub 2009 Sep 8.

PMID:
19737881
42.

Dynamic contour tonometry in eyes after penetrating keratoplasty.

Moreno-Montañés J, Olmo N, Zarranz-Ventura J, Heras-Mulero H.

Cornea. 2009 Aug;28(7):836-7. doi: 10.1097/ICO.0b013e3181a3c3d0. No abstract available.

PMID:
19574894
43.

[Corneal manifestations in systemic diseases].

Zarranz Ventura J, De Nova E, Moreno-Montañés J.

An Sist Sanit Navar. 2008;31 Suppl 3:155-70. Review. Spanish.

44.

Microplasmin: ex vivo characterization of its activity in porcine vitreous.

de Smet MD, Valmaggia C, Zarranz-Ventura J, Willekens B.

Invest Ophthalmol Vis Sci. 2009 Feb;50(2):814-9. doi: 10.1167/iovs.08-2185. Epub 2008 Sep 20.

PMID:
18806295
45.

Myopic choroidal neovascularization genetics.

Fernandez-Robredo P, Maestre SR, Zarranz-Ventura J, Mulero HH, Salinas-Alaman A, Garcia-Layana A.

Ophthalmology. 2008 Sep;115(9):1632, 1632.e1. doi: 10.1016/j.ophtha.2008.03.004. No abstract available.

PMID:
18762075

Supplemental Content

Loading ...
Support Center